These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 31311166)

  • 21. Metabolic modulation of epigenetics in gliomas.
    Venneti S; Thompson CB
    Brain Pathol; 2013 Mar; 23(2):217-21. PubMed ID: 23432648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory networks driving expression of genes critical for glioblastoma are controlled by the transcription factor c-Jun and the pre-existing epigenetic modifications.
    Roura AJ; Szadkowska P; Poleszak K; Dabrowski MJ; Ellert-Miklaszewska A; Wojnicki K; Ciechomska IA; Stepniak K; Kaminska B; Wojtas B
    Clin Epigenetics; 2023 Feb; 15(1):29. PubMed ID: 36850002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.
    Mur P; Rodríguez de Lope Á; Díaz-Crespo FJ; Hernández-Iglesias T; Ribalta T; Fiaño C; García JF; Rey JA; Mollejo M; Meléndez B
    J Neurooncol; 2015 May; 122(3):441-50. PubMed ID: 25682093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Epigenetic Mechanism of High Gdnf Transcription in Glioma Cells Revealed by Specific Sequence Methylation.
    Zhang BL; Liu J; Lei Y; Xiong Y; Li H; Lin X; Yao RQ; Gao DS
    Mol Neurobiol; 2016 Sep; 53(7):4352-62. PubMed ID: 26232065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interplay between different epigenetic modifications and mechanisms.
    Murr R
    Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas.
    Hersh DS; Peng S; Dancy JG; Galisteo R; Eschbacher JM; Castellani RJ; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
    J Neurooncol; 2018 Jun; 138(2):241-250. PubMed ID: 29453678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
    Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS
    Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic modification in gliomas: role of the histone methyltransferase EZH2.
    Bian EB; Li J; He XJ; Zong G; Jiang T; Li J; Zhao B
    Expert Opin Ther Targets; 2014 Oct; 18(10):1197-206. PubMed ID: 25046371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular genetic and epigenetic analysis of NCX2/SLC8A2 at 19q13.3 in human gliomas.
    Qu M; Jiao H; Zhao J; Ren ZP; Smits A; Kere J; Nistér M
    Neuropathol Appl Neurobiol; 2010 Apr; 36(3):198-210. PubMed ID: 20132488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
    Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N
    Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EGFR promoter exhibits dynamic histone modifications and binding of ASH2L and P300 in human germinal matrix and gliomas.
    Erfani P; Tome-Garcia J; Canoll P; Doetsch F; Tsankova NM
    Epigenetics; 2015; 10(6):496-507. PubMed ID: 25996283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic and epigenetic markers of gliomas].
    Semenova EV; Filatov MV
    Tsitologiia; 2013; 55(5):290-9. PubMed ID: 24592735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. THE ANALYSIS OF LGI1 GENE EPIGENETIC ALTERATIONS BY MEANS OF POSTTRANSLATIONAL H3 HISTONE MODIFICATIONS IN MALIGNANT GLIOMAS.
    Semenova EV; Volnitsky AV; Filatov MV
    Tsitologiia; 2016; 58(5):335-9. PubMed ID: 30188624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.
    Kim TY; Zhong S; Fields CR; Kim JH; Robertson KD
    Cancer Res; 2006 Aug; 66(15):7490-501. PubMed ID: 16885346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.
    Reich TR; Switzeny OJ; Renovanz M; Sommer C; Kaina B; Christmann M; Tomicic MT
    Oncotarget; 2017 Feb; 8(9):15071-15084. PubMed ID: 28122345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic Regulation of miR-129-2 Leads to Overexpression of PDGFRa and FoxP1 in Glioma Cells.
    Tian XY; Zhang L; Sun LG; Li M
    Asian Pac J Cancer Prev; 2015; 16(14):6129-33. PubMed ID: 26320507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies.
    Maury E; Hashizume R
    Epigenetics; 2017 May; 12(5):353-369. PubMed ID: 28059591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
    Zhao B; Bian EB; Li J; Li J
    J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An update on the epigenetics of glioblastomas.
    Ferreira WA; Pinheiro Ddo R; Costa Junior CA; Rodrigues-Antunes S; Araújo MD; Leão Barros MB; Teixeira AC; Faro TA; Burbano RR; Oliveira EH; Harada ML; Borges Bdo N
    Epigenomics; 2016 Sep; 8(9):1289-305. PubMed ID: 27585647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetics in human gliomas.
    Kreth S; Thon N; Kreth FW
    Cancer Lett; 2014 Jan; 342(2):185-92. PubMed ID: 22531315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.